← FDA DRUG APPROVALS
FDA ANDA · ANDA079159
LITHIUM CARBONATE LITHIUM CARBONATE
lithium carbonate
Sponsor: ALEMBIC LTD
APPLICATION
ANDA079159
TYPE
ANDA
ORIGINAL APPROVAL
2009-01-12
LATEST ACTION
2023-01-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 600MG · CAPSULE · ORAL
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 150MG · CAPSULE · ORAL
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 300MG · CAPSULE · ORAL
Approval history
2023-01-05Labeling · Supplement 12 · standardAP
2020-09-11Labeling · Supplement 8 · standardAP
2020-09-11Labeling · Supplement 2 · standardAP
2020-09-11Labeling · Supplement 5 · standardAP
2012-03-06Labeling · Supplement 1AP
2009-01-12OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.